Search Results - "Medulloblastoma / therapy"

Refine Results
  1. 1

    Source: Neuro-Oncology 26(11), 2113-2124 (2024). doi:10.1093/neuonc/noae092
    Mynarek, M, Rossius, A, Guiard, A, Ottensmeier, H, von Hoff, K, Obrecht-Sturm, D, Bußenius, L, Friedrich, C, von Bueren, A O, Gerber, N U, Traunwieser, T, Kortmann, R-D, Warmuth-Metz, M, Bison, B, Thomale, U-W, Krauss, J, Pietsch, T, Clifford, S C, Pfister, S M, Sturm, D, Sahm, F, Tischler, T & Rutkowski, S 2024, ' Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trial ', Neuro-Oncology . https://doi.org/10.1093/neuonc/noae092

    File Description: application/pdf

  2. 2
  3. 3

    Source: J Neurooncol
    Journal of neuro-oncology 157(1), 37-48 (2022). doi:10.1007/s11060-021-03913-5

    File Description: application/pdf; ZORA_228196.pdf - application/pdf

  4. 4

    Source: J Neurooncol
    Dirven, L, Luerding, R, Beier, D, Bumes, E, Reinert, C, Seidel, C, Bonsanto, M M, Bremer, M, Rieken, S, Combs, S E, Herrlinger, U, Seliger, C, Kuntze, H, Mayer-Steinacker, R, Dieing, A, Bartels, C, Schnell, O, Weyerbrock, A, Seidel, S, Grauer, O, Nadji-Ohl, M, Paulsen, F, Weller, M, Wick, W & Hau, P 2020, ' Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients : long-term outcomes of the NOA-07 study ', Journal of Neuro-Oncology, vol. 148, no. 1, pp. 117-130 . https://doi.org/10.1007/s11060-020-03502-y
    J. Neuro-Oncol. 148, 117-130 (2020)

    File Description: application/pdf; Dirven2020_Article_NeurocognitiveFunctioningAndHe.pdf - application/pdf; Manuscript_long_term_HRQoL_NCF_NOA07_revision_submitted.pdf - application/pdf; pdf

  5. 5
  6. 6

    Source: European journal of cancer, Vol. 51, No 17 (2015) pp. 2634-2642
    Pompe, R S, von Bueren, A O, Mynarek, M, von Hoff, K, Friedrich, C, Kwiecien, R, Treulieb, W, Lindow, C, Deinlein, F, Fleischhack, G, Kuehl, J & Rutkowski, S 2015, ' Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma : Feasibility, acute toxicity and evidence for efficacy ', European Journal of Cancer, vol. 51, no. 17, pp. 2634-42 . https://doi.org/10.1016/j.ejca.2015.08.009

    File Description: application/pdf

  7. 7
  8. 8
  9. 9
  10. 10

    Source: Arquivos Brasileiros de Endocrinologia & Metabologia v.55 n.8 2011
    Arquivos Brasileiros de Endocrinologia & Metabologia
    Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
    instacron:SBEM
    Arquivos Brasileiros de Endocrinologia & Metabologia, Volume: 55, Issue: 8, Pages: 653-660, Published: NOV 2011

    File Description: text/html

  11. 11

    Source: Neuro-oncology, Vol. 13, No 6 (2011) pp. 669-679
    von Bueren, A O, von Hoff, K, Pietsch, T, Gerber, N U, Warmuth-Metz, M, Deinlein, F, Zwiener, I, Faldum, A, Fleischhack, G, Benesch, M, Krauss, J, Kuehl, J, Kortmann, R D & Rutkowski, S 2011, ' Treatment of young children with localized medulloblastoma by chemotherapy alone : results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology ', Neuro-Oncology, vol. 13, no. 6, pp. 669-79 . https://doi.org/10.1093/neuonc/nor025

    File Description: application/pdf

  12. 12
  13. 13
  14. 14

    Source: European journal of cancer, Vol. 56 (2016) pp. 181-182
    Pompe, R S, von Bueren, A O, Mynarek, M, von Hoff, K & Rutkowski, S 2016, ' Reply to letter that comments on 'Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma : Feasibility, acute toxicity and evidence for efficacy' ', European Journal of Cancer, vol. 56, pp. 181-182 . https://doi.org/10.1016/j.ejca.2015.11.011

    File Description: application/pdf

  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20